김미랑 (한국생명공학연구원)님 | 한빛사연구자 > 한빛사

한국생명공학연구원

최종업데이트 2026.01.30.

DNMT1 Facilitates the Progression of MASLD by Impeding Transcription Mediated by HNF4α and PPARα
- Clin. Mol. Hepatol., Volume 32(3); July 2026 | https://doi.org/10.3350/cmh.2025.1099
- 2026-07
- 생명과학
- 한빛사논문
[Correspondence] Correspondence on Letter regarding "A complement to epigenetics in MASLD"
- Clin. Mol. Hepatol., Sep 10 2024, | https://doi.org/10.3350/cmh.2024.0761
- 2024-09
- 의약학
- 한빛사논문
DNA methylome analysis reveals epigenetic alteration of complement genes in advanced metabolic dysfunction-associated steatotic liver disease
- Clin. Mol. Hepatol., 2024 Jul 25 | https://www.e-cmh.org/journal/view.php?doi=10.3350/cmh.2024.0229
- 2024-07
- 바이오·의료융합
- 한빛사논문
DNA methylome and single-cell transcriptome analyses reveal CDA as a potential druggable target for ALK inhibitor-resistant lung cancer therapy
- Exp. Mol. Med., 2022 Aug;54(8):1236-1249. | doi: 10.1038/s12276-022-00836-7
- 2022-08
- 생명과학
- 한빛사논문
H2B monoubiquitylation is a 5'-enriched active transcription mark and correlates with exon-intron structure in human cells
- Genome Res., Published in Advance March 15, 2012, doi: 10.1101/gr.120634.111
- 2012-03
- 생명과학
- 한빛사논문

연구자 ID

저자논문